96 studies found for:    "Bacterial meningitis"
Show Display Options
Rank Status Study
1 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
2 Completed Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Glycerol and paracetamol;   Drug: Paracetamol;   Drug: Placebo;   Drug: Paracetamol and glycerol;   Drug: Glycerol
3 Not yet recruiting Vitamin d Levels in Children With Bacterial Meningitis
Condition: Bacterial Meningitis
Intervention:
4 Unknown  Infant Severe Sepsis and Bacterial Meningitis in Malawi
Condition: Infant Bacterial Meningitis
Intervention: Drug: Ceftriaxone v penicillin and gentamicin
5 Active, not recruiting Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae
Condition: Meningitis, Bacterial
Intervention:
6 Unknown  Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
7 Active, not recruiting DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Conditions: Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis;   Bacterial Meningitis
Interventions: Biological: DTaP-IPV/Hib Combined vaccine;   Biological: DTaP-IPV vaccine and Hib vaccine
8 Completed
Has Results
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
9 Completed
Has Results
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
10 Completed Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Conditions: Neurological Disorders;   Cerebral Malaria;   Bacterial Meningitis;   Central Nervous System Tuberculosis;   Neurosyphilis;   Cryptococcal Meningitis
Interventions: Device: Immunochromatographic HAT tests (DSD);   Device: Card Agglutination Trypanosoma Test;   Device: TB POC Nucleic Acid Amplification Test (Molbio Diagnostics);   Device: TB 3-marker RDT (Tulip diagnostics);   Device: Cryptococcal Antigen Lateral Flow Assay (Immy)
11 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
12 Terminated IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Condition: Bacterial Meningitis
Interventions: Procedure: Mild induced hypothermia (32-34°C);   Procedure: local recommendations and guidelines
13 Withdrawn Amikacin Penetration Into the Cerebrospinal Fluid
Conditions: Gram Negative Meningitis;   Post Traumatic Bacterial Meningitis
Intervention: Drug: Systemic and Intra-Thecal Amikacin Therapy
14 Completed Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)
Conditions: Neisseria Meningitidis (Bacterial Meningitis);   Invasive Pneumococcal Disease (IPD)
Interventions: Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT)
15 Recruiting Daptomycin in Pediatric Patients With Bacterial Meningitis
Condition: Meningitis
Intervention: Drug: Daptomycin
16 Recruiting Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W 135 Combined
17 Recruiting Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
18 Active, not recruiting Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
19 Not yet recruiting Ciprofloxacin for the Prevention of Meningococcal Meningitis
Condition: Meningitis, Meningococcal
Intervention: Drug: Ciprofloxacin
20 Recruiting Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation
Conditions: Meningitis;   Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years